FRISKA

Minneapolis, United States Founded: 2018 • Age: 8 yrs Acquired By Megalabs
Manufacturer of nutritional supplements for multiple health ailments

About FRISKA

FRISKA is a Healthcare company based in Minneapolis (United States) founded in 2018, and was acquired by Megalabs in December 2022. Manufacturer of nutritional supplements for multiple health ailments. FRISKA offers products and services including Men's Daily, Women's Daily, and Nightly Reboot. Its focus areas include Life Sciences, Nutraceuticals Tech, Dietary Supplements and Disease Specific. Its legal entity is Megalabs USA, LLC. Its competitors include ChromaDex, LifeVantage and Bloom Nutrition; 1 of its 3 listed competitors has raised funding.

Company details

FRISKA was founded in 2018 and is based in Minneapolis, United States. Operations focus on the nutritional supplements sector, where capsule and collagen-based products are developed. Formulations incorporate enzymes, probiotics, and botanicals to address womens health, mens health, energy boosting, immune support, and other ailments. The companys activities center on production for diverse health needs within the United States market.

  • Headquarters Minneapolis, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website getfriska.com
  • Social LinkedIn X Facebook Instagram
  • Acquired by Megalabs (Dec 2022)
  • Legal Name Megalabs Usa, Llc
Key Metrics

Products & Services of FRISKA

FRISKA offers a comprehensive portfolio of products and services, including Men's Daily, Women's Daily, and Nightly Reboot.

Men's Daily
Probiotic Supplement

Supports digestion of nutrients and immune system for adult men.

Women's Daily
Probiotic Supplement

Promotes digestion and urinary tract health for women.

Nightly Reboot
Probiotic Supplement

Aids digestion and enhances sleep quality at night.

Investors in FRISKA

FRISKA has secured backing from 1 investor. Prominent investors backing the company include Megalabs.

All
InvestorDescriptionFounded YearDomainLocation
Diversified pharmaceutical products are developed and distributed globally by Megalabs.
2003megalabs.globalCanelones, Uruguay
Premium access

Investor details for FRISKA

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of FRISKA

2 dated milestones of FRISKA across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded FRISKA is founded.
  2. Exit Acquired by Megalabs.

Competitors of FRISKA

FRISKA has 3 listed competitors in our database, 1 of them funded. They include ChromaDex, LifeVantage and Bloom Nutrition.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
chromadex.com1999Irvine, United States$3.35M228
Nutritional ingredients for health and wellness are developed.
lifevantage.com2003Monroe, United States248
Nutritional products for various health ailments are provided.
bloomnu.com2019Venice, United States41
Health and wellness nutritional supplements are provided by Bloom Nutrition.
Premium access

Detailed competitors of FRISKA

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of FRISKA

The website of FRISKA (getfriska.com) receives about 1.4K visits a month.

  • Monthly visits
    1.4K

    ▲ 9.6% vs previous month

Top companies in Nutraceutical & Food-as-Medicine Platforms

3 companies that operate in the same segment as FRISKA (Nutraceutical & Food-as-Medicine Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Therapies for metabolic health in chronic disease patients are provided.
2014San Francisco, California, United StatesUSD 401.78 M910
Personalized gut health solutions are provided by ZOE.
2017New Castle, Pennsylvania, United StatesUSD 15 M
Machine learning-based bioinformatics solutions for health insights are provided.
2016Los Alamos, New Mexico, United StatesUSD 301.57 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Friska

Premium access

Complete news archive for FRISKA

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about FRISKA

FRISKA was founded in 2018.

FRISKA is headquartered in Minneapolis, United States. It is registered at Minneapolis, Minnesota, United States.

FRISKA was founded in 2018 and is based in Minneapolis, United States. Operations focus on the nutritional supplements sector, where capsule and collagen-based products are developed. Formulations incorporate enzymes, probiotics, and botanicals to address womens health, mens health, energy boosting, immune support, and other ailments. The companys activities center on production for diverse health needs within the United States market.

FRISKA's top competitors include ChromaDex, LifeVantage and Bloom Nutrition.

FRISKA offers Men's Daily, Women's Daily, and Nightly Reboot.

FRISKA has 1 investor. Key investors include Megalabs.

FRISKA operates through Megalabs Usa, Llc.

Yes. FRISKA was acquired by Megalabs in December 2022.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available